Cancer therapy: know your enemy?

BACKGROUND: Most cancer therapies are devised for adult or even elder patients. However, when dealing with pediatric cancers, additional considerations are needed. CONCLUSIONS: This review discusses non-classic components of tumors and highlights possible treatment approaches which might be of parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Westhoff, Mike-Andrew, Brühl, Oliver, Debatin, Klaus-Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530549/
https://www.ncbi.nlm.nih.gov/pubmed/26567104
http://dx.doi.org/10.1186/s40348-014-0010-2
_version_ 1782384917540241408
author Westhoff, Mike-Andrew
Brühl, Oliver
Debatin, Klaus-Michael
author_facet Westhoff, Mike-Andrew
Brühl, Oliver
Debatin, Klaus-Michael
author_sort Westhoff, Mike-Andrew
collection PubMed
description BACKGROUND: Most cancer therapies are devised for adult or even elder patients. However, when dealing with pediatric cancers, additional considerations are needed. CONCLUSIONS: This review discusses non-classic components of tumors and highlights possible treatment approaches which might be of particular benefit for children and adolescents.
format Online
Article
Text
id pubmed-4530549
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-45305492015-08-19 Cancer therapy: know your enemy? Westhoff, Mike-Andrew Brühl, Oliver Debatin, Klaus-Michael Mol Cell Pediatr Mini Review BACKGROUND: Most cancer therapies are devised for adult or even elder patients. However, when dealing with pediatric cancers, additional considerations are needed. CONCLUSIONS: This review discusses non-classic components of tumors and highlights possible treatment approaches which might be of particular benefit for children and adolescents. Springer Berlin Heidelberg 2014-10-31 /pmc/articles/PMC4530549/ /pubmed/26567104 http://dx.doi.org/10.1186/s40348-014-0010-2 Text en © Westhoff et al.; licensee Springer. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Mini Review
Westhoff, Mike-Andrew
Brühl, Oliver
Debatin, Klaus-Michael
Cancer therapy: know your enemy?
title Cancer therapy: know your enemy?
title_full Cancer therapy: know your enemy?
title_fullStr Cancer therapy: know your enemy?
title_full_unstemmed Cancer therapy: know your enemy?
title_short Cancer therapy: know your enemy?
title_sort cancer therapy: know your enemy?
topic Mini Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530549/
https://www.ncbi.nlm.nih.gov/pubmed/26567104
http://dx.doi.org/10.1186/s40348-014-0010-2
work_keys_str_mv AT westhoffmikeandrew cancertherapyknowyourenemy
AT bruhloliver cancertherapyknowyourenemy
AT debatinklausmichael cancertherapyknowyourenemy

Ejemplares similares